Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Silo Pharma, Inc. (SILO) had Normalized Pre-Tax Income of $-1.20M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.02M |
|
$-1.20M |
|
$0.00M |
|
$0.02M |
|
$1.27M |
|
$-1.25M |
|
$0.04M |
|
$-1.20M |
|
|
Normalized Pre-Tax Income |
$-1.20M |
$-1.20M |
|
$-1.20M |
|
$-1.20M |
|
$-1.20M |
|
$-1.25M |
|
$-1.25M |
|
6.28M |
|
6.28M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$6.37M |
|
-- |
|
$0.28M |
|
$6.65M |
|
$1.05M |
|
-- |
|
$0.69M |
|
$1.74M |
|
$4.92M |
|
$4.69M |
|
$4.92M |
|
8.65M |
|
| Cash Flow Statement Financials | |
$-2.93M |
|
$1.26M |
|
$2.09M |
|
$3.91M |
|
$4.33M |
|
$0.43M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.91% |
|
-6926.77% |
|
-6926.77% |
|
-- |
|
-6681.24% |
|
-6681.24% |
|
$-2.93M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-24.49% |
|
-25.66% |
|
-18.10% |
|
-24.49% |
|
$0.57 |
|
$-0.47 |
|
$-0.47 |
|